GENFF (Genflow Biosciences) Ending Cash Position : $1.45 Mil (As of Jun. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Genflow Biosciences Ending Cash Position?

Genflow Biosciences's Ending Cash Position for the quarter that ended in Jun. 2024 was $1.45 Mil.

Genflow Biosciences's quarterly Ending Cash Position declined from Jun. 2023 ($1.90 Mil) to Dec. 2023 ($0.87 Mil) but then increased from Dec. 2023 ($0.87 Mil) to Jun. 2024 ($1.45 Mil).

Genflow Biosciences's annual Ending Cash Position increased from Dec. 2021 ($0.30 Mil) to Dec. 2022 ($2.87 Mil) but then declined from Dec. 2022 ($2.87 Mil) to Dec. 2023 ($0.87 Mil).

Genflow Biosciences Ending Cash Position Historical Data

The historical data trend for Genflow Biosciences's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genflow Biosciences Ending Cash Position Chart

Genflow Biosciences Annual Data

Trend

Dec21

Dec22

Dec23

Ending Cash Position

0.30

2.87

0.87

Genflow Biosciences Semi-Annual Data
	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Ending Cash Position	Get a 7-Day Free Trial			3.63	2.87	1.90	0.87	1.45

Genflow Biosciences Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Genflow Biosciences's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	2.982	+	-2.116
	=	0.87

Genflow Biosciences's Ending Cash Position for the quarter that ended in Jun. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	0.869	+	0.581
	=	1.45

Genflow Biosciences Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Genflow Biosciences's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Genflow Biosciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genflow Biosciences PLC (OTCPK:GENFF) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

GENF:UK

Address

6 Heddon Street, London, GBR, W1B 4BT

Website

https://www.genflowbio.com

Genflow Biosciences PLC is a preclinical biotechnology company focused on developing innovative biological interventions aimed at tackling the effects of aging, potentially slowing or halting the aging process and reducing the incidence of age-related diseases and thereby increasing life span. The company is also focused on longevity and the development of therapies to counteract the effects of aging and diseases associated with age.